Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against the variola virus, the causative agent of smallpox, and has therefore been ...

Scientists at Oregon Health & Science University are working on advancing that goal by developing a new way to deliver vaccines against flu viruses. The vaccines are delivered through a harmless virus ...

In a press release from the University of California — Riverside, one of the researchers behind the new RNA vaccine, Rong Hai, explained why he and his colleagues are so excited about their ...

What if CAR T cells, revolutionary cancer fighters normally manufactured in the lab, could be created inside the patient? This quest to simplify CAR T therapy has brought two biotech companies to a ...

For the past few years, SARS-CoV-2 and mRNA-based vaccines have dominated the scientific and clinical work on infectious diseases, but other diseases and vaccine approaches are attracting attention.

Gene therapy involves the introduction of foreign genomic materials into host cells to trigger clinical benefits. 1 Over the years, scientists have developed numerous viral and non-viral vectors to ...